The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular profiling of serial liquid biopsy specimens utilizing cell free DNA (cfDNA) and circulating tumor cells (CTCs) in TBCRC041: A phase II study of alisertib in endocrine resistant metastatic breast cancer (MBC).
 
Karthik Giridhar
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo (Inst); Exact Sciences (Inst); Gilead Sciences (Inst); Lilly (Inst); MJH Live Events (Inst); MJH Live Events (Inst); NeoGenomics Laboratories (Inst); Puma Biotechnology (Inst); Tersera (Inst)
Research Funding - Guardant Health (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - GRAIL; QuantumLeap Health
 
Vera Jean Suman
No Relationships to Disclose
 
Xiaojia Tang
No Relationships to Disclose
 
Hong Ye
No Relationships to Disclose
 
Jordan Campbell
No Relationships to Disclose
 
Erica L. Mayer
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis
 
Meghan Sri Karuturi
No Relationships to Disclose
 
Aki Morikawa
Consulting or Advisory Role - Eisai; Lilly; Seagen
Research Funding - Dantari Pharmaceuticals (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); F. Hoffmann LaRoche (Inst); Freenome (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck Sharp & Dohme Corp. (Inst); Merrimack (Inst); Millenium Pharamceuticals (Inst); Molecular Templates (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Suzhou Zanrong Pharma (Inst); Tempus (Inst)
Other Relationship - Taiho Pharmaceutical
(OPTIONAL) Uncompensated Relationships - Puma Biotechnology
 
Gretchen Genevieve Kimmick
Honoraria - Research to Practice
Consulting or Advisory Role - bioTheranostics; Immunomedics; Novartis
Research Funding - Novartis (Inst); Pfizer (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for CardioOncology textbook from Springer.; Royalties from Springer for textbook "Common Issues in Breast Cancer Survivors: A Practical Guide to Evaluation and Management."; UpToDate Royalties
 
Claudine Isaacs
Honoraria - Pfizer; Pfizer
Consulting or Advisory Role - AstraZeneca/MedImmune; Gilead Sciences; Ion Solutions; Novartis; Pfizer; Puma Biotechnology; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Elsevier - Editor of Book; McGraw Hill Publishing; UpToDate - Wolters Kluwer - Author of chapters
Travel, Accommodations, Expenses - Pfizer
Other Relationship - Curio/Vaniam Group; Medscape; MJH/PER; Side-Out Foundation
 
Sun Young Oh
No Relationships to Disclose
 
Amy Sanders Clark
Honoraria - Siemens
Consulting or Advisory Role - Novartis
Research Funding - Lilly (Inst); Novartis (Inst); Seagen (Inst)
 
Ben Ho Park
Leadership - Loxo
Stock and Other Ownership Interests - Celcuity; Loxo
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Casdin Capital; Celcuity; EQRx; Guardant Health; Hologic; Horizon Discovery; Jackson Laboratory for Genomic Medicine; Janssen; Loxo; Sermonix Pharmaceuticals
Research Funding - Abbvie; GE Healthcare; Lilly; Pfizer
Patents, Royalties, Other Intellectual Property - Royalties paid through inventions at Johns Hopkins University by Horizon Discovery LTD
Travel, Accommodations, Expenses - Lilly; Loxo
(OPTIONAL) Uncompensated Relationships - Tempus
 
Leslie A Bucheit
Employment - Guardant Health; Myriad Genetics
Stock and Other Ownership Interests - Guardant Health
 
Jill Tsai
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health; Guardant Health (I); Guardant Health (Inst)
Research Funding - Guardant Health
Travel, Accommodations, Expenses - Guardant Health
 
James N. Ingle
No Relationships to Disclose
 
Matthew P. Goetz
Consulting or Advisory Role - ARC Therapeutics (Inst); AstraZeneca (Inst); BioTheryX; Blueprint Medicines (Inst); Engage Health Media (Inst); Genzyme (Inst); Laekna Therapeutics; Lilly (Inst); Novartis (Inst); Rna Diagnostics (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Tersera
Research Funding - AstraZeneca (Inst); Atossa Genetics (Inst); Lilly (Inst); Loxo (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Development of Human Tumor Xenografts from Women with Breast Cancer Treated with Neoadjuvant Chemotherapy (Inst); Methods and Materials for Assessing Chemotherapy Responsiveness and Treating Cancer; METHODS AND MATERIALS FOR USING BUTYRYLCHOLINESTERASES TO TREAT CANCER
Travel, Accommodations, Expenses - Lilly (Inst)
 
Antonino Bonaventura D'assoro
No Relationships to Disclose
 
Krishna Rani Kalari
No Relationships to Disclose
 
Tufia C. Haddad
Consulting or Advisory Role - Puma Biotechnology (Inst)
Research Funding - Takeda (Inst)